ATE287430T1 - Oxazinderivate - Google Patents

Oxazinderivate

Info

Publication number
ATE287430T1
ATE287430T1 AT01978341T AT01978341T ATE287430T1 AT E287430 T1 ATE287430 T1 AT E287430T1 AT 01978341 T AT01978341 T AT 01978341T AT 01978341 T AT01978341 T AT 01978341T AT E287430 T1 ATE287430 T1 AT E287430T1
Authority
AT
Austria
Prior art keywords
reactive group
test material
binding
contain
phenazoxonium
Prior art date
Application number
AT01978341T
Other languages
German (de)
English (en)
Inventor
Joachim Fries
Eloisa Lopez-Calle
Karl-Heinz Drexhage
Dirk Winkler
Original Assignee
Evotec Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00127005A external-priority patent/EP1213328A1/de
Application filed by Evotec Ag filed Critical Evotec Ag
Application granted granted Critical
Publication of ATE287430T1 publication Critical patent/ATE287430T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B19/00—Oxazine dyes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
AT01978341T 2000-09-06 2001-09-05 Oxazinderivate ATE287430T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00119292 2000-09-06
EP00127005A EP1213328A1 (de) 2000-12-08 2000-12-08 Oxazinderivate
PCT/EP2001/010236 WO2002020670A1 (de) 2000-09-06 2001-09-05 Oxazinderivate

Publications (1)

Publication Number Publication Date
ATE287430T1 true ATE287430T1 (de) 2005-02-15

Family

ID=26071369

Family Applications (2)

Application Number Title Priority Date Filing Date
AT01978341T ATE287430T1 (de) 2000-09-06 2001-09-05 Oxazinderivate
AT05000174T ATE518913T1 (de) 2000-09-06 2001-09-05 Verfahren zur gezielten markierung mittels affinitätsmarkierter detektionsmarker

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05000174T ATE518913T1 (de) 2000-09-06 2001-09-05 Verfahren zur gezielten markierung mittels affinitätsmarkierter detektionsmarker

Country Status (6)

Country Link
US (2) US7101999B2 (enExample)
EP (2) EP1317511B1 (enExample)
JP (1) JP2004508448A (enExample)
AT (2) ATE287430T1 (enExample)
DE (1) DE50105139D1 (enExample)
WO (1) WO2002020670A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE287430T1 (de) 2000-09-06 2005-02-15 Evotec Ag Oxazinderivate
DE10212960A1 (de) * 2002-03-22 2003-10-23 Gnothis Holding Sa Ecublens Verwendung von Oxazin-Farbstoffen als Markierungsgruppen für die Einzelmolekülanalyse
MXPA06001891A (es) * 2003-08-18 2006-05-17 Novartis Ag Derivados de 3h-fenoxazina adecuados como agentes para la formacion de imagenes casi-infrarrojas, preparacion y uso de los mismos.
US7326258B2 (en) 2004-06-18 2008-02-05 L'oreal S.A. Compositions comprising hydroxyalkyl direct dyes, implementation processes and uses thereof
EP1607393A1 (fr) * 2004-06-18 2005-12-21 L'oreal Compositions comprenant des colorants directs hydroxyalkyles, procédés de mise en oeuvre et utilisations.
WO2009107448A1 (ja) * 2008-02-29 2009-09-03 独立行政法人理化学研究所 チオールの検出方法
US20120010404A1 (en) * 2008-06-10 2012-01-12 Sigma-Aldrich Co. Oxazine dyes with improved aqueous solubility
GB0903348D0 (en) * 2009-02-27 2009-04-08 Pharmalucia Ltd Compounds and methods relating thereto
CN103044947B (zh) * 2013-01-09 2014-05-21 大连理工大学 一类尼罗蓝荧光染料，其制备方法及应用
AU2014342254B2 (en) 2013-10-31 2020-03-26 Beth Israel Deaconess Medical Center Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
WO2015066296A1 (en) 2013-10-31 2015-05-07 Beth Israel Deaconess Medical Center Near-infrared fluorescent nerve contrast agents and methods of use thereof
US12440585B2 (en) 2023-09-12 2025-10-14 Curadel Surgical Innovations, Inc. Zwitterionic metal chelators

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE287040C (enExample)
US1488609A (en) * 1924-04-01 murphy
JPS501576B2 (enExample) * 1972-04-25 1975-01-20
GB1410815A (en) * 1972-12-20 1975-10-22 Ici Ltd Oxazine dyestuffs
DE2411761A1 (de) * 1974-03-12 1975-10-16 Hoechst Ag Basische oxazinfarbstoffe, verfahren zu ihrer herstellung und ihre verwendung
US4622395A (en) * 1984-10-01 1986-11-11 Minnesota Mining And Manufacturing Company Phenoxazine and phenothiazine dyes and leuco forms thereof
US4714763A (en) * 1985-07-11 1987-12-22 Viomedics Inc. Novel oxazine-ureas and thiazine urea chromophors as fluorescent labels
US4780535A (en) * 1986-11-21 1988-10-25 Spyros Theodoropulos Maleic and phthalic diamides
US4965349A (en) * 1987-12-24 1990-10-23 Applied Biosystems, Inc. Method of synthesizing oligonucleotides labeled with ammonia-labile groups on solid phase supports
US4962197A (en) * 1988-02-12 1990-10-09 Rowland Institute For Science Photo-inactivation of cancer cells
IL91673A0 (en) 1988-09-20 1990-04-29 Us Health Method for tagging an oligodeoxynucleotide
DD287040A5 (de) * 1989-07-28 1991-02-14 Veb Forschungszentrum Biotechnologie Berlin,De Neue fluophorderivate, verfahren zu ihrer herstellung und deren verwendung zur herstellung neuartiger fluoreszenzmarkierter nucleoside, nucleotide und oligonucleotide
GB9024775D0 (en) * 1990-11-14 1991-01-02 Axis Research Chemical compounds
US5344928A (en) * 1991-04-26 1994-09-06 Takeda Chemical Industries, Ltd. Phenothiazine derivatives, their production and use
JPH05170752A (ja) * 1991-04-26 1993-07-09 Takeda Chem Ind Ltd ３，７−ビス（ジ置換アミノ）フェノチアジン誘導体およびその製造法
DE59309805D1 (de) 1992-12-15 1999-11-04 Ciba Sc Holding Ag Oxazinfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
US5656759A (en) 1993-07-22 1997-08-12 Sony Corporation Hydrophobic cationic dye compounds
US5792389A (en) * 1993-10-27 1998-08-11 United States Of America Water soluble laser dyes
US5620842A (en) * 1995-03-29 1997-04-15 Becton Dickinson And Company Determination of the number of fluorescent molecules on calibration beads for flow cytometry
DE19521231A1 (de) 1995-06-10 1996-12-12 Boehringer Mannheim Gmbh Neue Oxazinfarbstoffe und ihre Verwendung als Fluoreszenzmarker
GB9602265D0 (en) * 1996-02-05 1996-04-03 Amersham Int Plc Benzophenoxazine dyes
GB9716476D0 (en) * 1997-08-04 1997-10-08 Amersham Int Plc Dye intermediate and method
FR2780791B1 (fr) 1998-07-03 2000-09-01 Bio Merieux Methode de depistage ou de diagnostic d'un adenocarcinome ou d'une pathologie benigne de la prostate et procede de mise en oeuvre
US6140500A (en) 1999-09-03 2000-10-31 Pe Corporation Red-emitting [8,9]benzophenoxazine nucleic acid dyes and methods for their use
US6727356B1 (en) 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
US6465644B1 (en) * 2000-05-02 2002-10-15 Applera Corporation Sulfonated [8,9] benzophenoxazine dyes and the use of their labelled conjugates
ATE287430T1 (de) 2000-09-06 2005-02-15 Evotec Ag Oxazinderivate
ES2245995T3 (es) * 2000-11-16 2006-02-01 F. Hoffmann-La Roche Ag Pares de colorantes para mediciones de transferencia de energia de fluorescencia-resonancia (fret).

Also Published As

Publication number Publication date
EP1317511B1 (de) 2005-01-19
ATE518913T1 (de) 2011-08-15
US20060240455A1 (en) 2006-10-26
DE50105139D1 (en) 2005-02-24
EP1317511A1 (de) 2003-06-11
EP1535967A1 (de) 2005-06-01
EP1535967B1 (de) 2011-08-03
US7101999B2 (en) 2006-09-05
JP2004508448A (ja) 2004-03-18
US20040029837A1 (en) 2004-02-12
WO2002020670A1 (de) 2002-03-14

Similar Documents

Publication Publication Date Title
ATE287430T1 (de) Oxazinderivate
EA200000334A1 (ru) Производные карбоксамидотиазолов, их получение, содержащие их фармацевтические композиции
BR0009040A (pt) Método para acilar um grupo amino de um peptìdeoou de uma proteìna, e, composto
DE69512797D1 (en) Prostaglandin-synthase hemmer
BR0307408A (pt) Tripeptìdeos tendo um éter de hidroxipolina de uma quinolina substituìda para a inibição de ns3 (hepatite c)
DE69912581D1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
MY141224A (en) Crystalline form of a biphenyl compound
EA200200628A1 (ru) Новые производные 1,3-дигидро-2н-индол-2-она и их применение в качестве лигандов рецепторов аргинин-вазопрессина v1b и v1a
DE3484691D1 (de) Konjugierte vinblastin-verbindungen und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
HUP0002514A2 (hu) [5-Aril-2-(aril-amino)-fenil]-ecetsavak és származékaik
BR9509665A (pt) Composto composições e métodos
DE69918465D1 (de) Sulfonamidhydroxamate
ATE236176T1 (de) Neue substrate zur detektion von mikrobiellen metaboliten
ATE149164T1 (de) Neue tetrazolderivate, verfahren zu ihrer herstellung und ihre verwendung
ES2186615T3 (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
DE69931051D1 (de) Neue vinylbenzolderivate
IE812683L (en) Thieno-pyridine derivatives
DE69735845D1 (de) Kristalle von vitamin d derivaten und verfahren zu ihrer herstellung
NO833648L (no) Fenylinderivater, syreaddisjonssalter derav og fremgangsmaater ved fremstilling av disse
DK1156058T3 (da) Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
DE69824855D1 (de) Macrozyklische laktone, zusammensetzungen und verfahren zur verwendung
DE502007003971D1 (de) 3,4 diaminopyridin-derivate
ES2188464T3 (es) Procedimiento para la obtencion de esteres de n-acil-aminoacidos y n-acil-aminoacetales.
DE602004023640D1 (de) Neues verfahren zur herstellung von 3-fluorierten chinolinen
BG106916A (bg) Метод за получаване на естери на арил-иминометил-карбаминова киселина

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee